Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)
ClinicalTrials.gov ID
NCT00370786
Lead Sponsor
Shahid Beheshti University of Medical SciencesOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Phase 3
Enrollment
31Actual
Last Update Posted
Jul 11, 2008Estimated
Start Date
Nov 2005
Primary Completion Date
Nov 2007Actual
Completion Date
Feb 2008Actual
Brief Summary
To evaluate the effect of bevacizumab for treatment of non-AMD choroidal neovascularization (CNV); eg:angioid streaks, ocular histoplasmosis, high myopia, idiopathic,etc
Choroidal Neovascularization
bevacizumab
Ages Eligible for Study
Child (0-17)Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Cases with subfoveal or juxtafoveal CNV due to a non-AMD related cause.
Exclusion Criteria:
Evidence of AMD
Primary Purpose
Treatment
Allocation
Non-Randomized
Interventional Model
Single Group Assignment
Masking
None (Open Label)
No central contacts
There are no central contacts for this study.
Hamid Ahmadieh, MD
Tehran, Tehran Province 16666, Iran
Lead Sponsor
Shahid Beheshti University of Medical SciencesOTHER